Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...

Popular television actress Dipika Kakar, known for her roles in Indian daily soaps and reality television shows, has recently ...

CA125, AFP, and CEA are commonly used clinical tumor markers. Existing research (14) has applied the aforementioned factors to the diagnosis, treatment evaluation, and prognosis of digestive system ...

Report Ocean has published a new report on the Saudi Arabia Tumor Markers Testing Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...

Of these, 16,653 (42%) received at least one tumor marker assessment, averaging 5.7 tests over 2 years, with rates of use per person increasing over time. Factors significantly associated with use ...

Treatment of poor-risk non seminomatous germ-cell tumors (NSGCT) adapted by tumor marker decline: A 7-year multicenter real-world experience.

The development of guidelines for the reporting of tumor marker studies was a major recommendation of the National Cancer Institute–European Organisation for Research and Treatment of Cancer ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Liver problems have been increasing for the last few years. Millions of people around the world are worried about their liver ...

BluePrint further stratified these tumors into Basal or Luminal B subtypes, offering a more nuanced view of tumor biology and potential treatment response. The poster presentation, titled “The ...